[go: up one dir, main page]

GB1196229A - Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same - Google Patents

Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same

Info

Publication number
GB1196229A
GB1196229A GB1380069A GB1380069A GB1196229A GB 1196229 A GB1196229 A GB 1196229A GB 1380069 A GB1380069 A GB 1380069A GB 1380069 A GB1380069 A GB 1380069A GB 1196229 A GB1196229 A GB 1196229A
Authority
GB
United Kingdom
Prior art keywords
glyoxylic acid
acid salt
relating
preparation
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1380069A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOUDE LAB
Original Assignee
HOUDE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOUDE LAB filed Critical HOUDE LAB
Publication of GB1196229A publication Critical patent/GB1196229A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,196,229. Glyoxylic acid salt. LABORATOIRES MOUDE. 17 March, 1969 [22 March, 1968], No. 13800/69. Heading C2C. Novel papaverine glyoxylate is prepared by reacting equimolar amounts of papaverine and glyoxylic acid in the presence of an inert organic diluent and crystallizing out the salt. Pharmaceutical compositions comprise the novel salt in conjunction with a suitable carrier or diluent, are administered orally, rectally or parenterally and are useful in the treatment of cardiovascular diseases, spasmodic conditions of the digestive tract, nephrocolic and vesical spasms.
GB1380069A 1968-03-22 1969-03-17 Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same Expired GB1196229A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR144905A FR314F (en) 1968-03-22 1968-03-22

Publications (1)

Publication Number Publication Date
GB1196229A true GB1196229A (en) 1970-06-24

Family

ID=8647868

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1380069A Expired GB1196229A (en) 1968-03-22 1969-03-17 Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same

Country Status (4)

Country Link
BE (1) BE729914A (en)
DE (1) DE1914456A1 (en)
FR (1) FR314F (en)
GB (1) GB1196229A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US8153621B2 (en) 2004-12-23 2012-04-10 Arena Pharmaceuticals, Inc. 5ht2C receptor modulator compositions
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8299241B2 (en) 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
US10226471B2 (en) 2010-09-01 2019-03-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946207B2 (en) 2003-06-17 2015-02-03 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US8367657B2 (en) 2003-06-17 2013-02-05 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8404675B2 (en) 2003-06-17 2013-03-26 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases
US9102627B2 (en) 2003-06-17 2015-08-11 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
US8546378B2 (en) 2004-12-23 2013-10-01 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
US8153621B2 (en) 2004-12-23 2012-04-10 Arena Pharmaceuticals, Inc. 5ht2C receptor modulator compositions
US8168782B2 (en) 2006-04-03 2012-05-01 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8501935B2 (en) 2006-04-03 2013-08-06 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8802845B2 (en) 2006-04-03 2014-08-12 Arena Phamaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto
US8299241B2 (en) 2006-12-05 2012-10-30 Arena Pharmaceuticals, Inc. Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US9248133B2 (en) 2010-09-01 2016-02-02 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
US9770455B2 (en) 2010-09-01 2017-09-26 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
US10226471B2 (en) 2010-09-01 2019-03-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management
US10463676B2 (en) 2010-09-01 2019-11-05 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonists useful for weight management
US9169213B2 (en) 2012-10-09 2015-10-27 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
DE1914456A1 (en) 1971-06-16
BE729914A (en) 1969-09-15
FR314F (en) 1970-05-25

Similar Documents

Publication Publication Date Title
GB1432576A (en) Substituted phenylacetic acids
GB1196229A (en) Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same
GB1436978A (en) Choline derivatives and pharmaceutical compositions containing the same
GB1308028A (en) Thiazolylbenzoic acid derivatives and a process for their manufactur
IL33846A (en) Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them
GB1265279A (en)
GB1377198A (en) Thia-heterocyclic compounds
GB1490486A (en) 4-imino-1,3-diazobicyclo-(3.1.0)hexan-2-one
GB1084256A (en)
GB1378068A (en) Citric acid derivatives
GB1458217A (en) Distributed azabicycloalkanes a process for their preparation and pharmaceutical compositions containing them
GB1427114A (en) Derivatives of 3- p-chlorobenoyl-2-methyl-phenylacetic acid
GB1411700A (en) Penicillins and production thereof
GB1503447A (en) Dl-and 8r-9-fluoro-prostadienoic acid derivatives and process
GB1515614A (en) Preparation of m-benzoylhydratropic acid and an intermediate therefor
GB1139164A (en) New heterocyclic acetic acid compounds and methods for their production
GB1219387A (en) Bicyclo[2.2.2]oct-2-ene-amino acid compounds
US3804888A (en) 2-p-nitrobenzamidoacetohydroxamic acid
GB1333524A (en) Penicilloic acid derivatives
IE34307B1 (en) New 1-alkyl-6-azauracil compounds and preparations which contain a 1-alkyl-6-azauracil compound as an active ingredient
GB1242096A (en) Benzobenzofuranooxepine compounds and process for preparing the same
GB1322207A (en) Alpha-ureidocyclohexadienylalkylene penicillins
GB1489784A (en) Pharmaceutically active substituted keto-acid derivatives
GB1322069A (en) Aminoalkanoylaminocyclohexane derivatives
GB1472257A (en) Derivative of 4-hydroxy-5-azacoumarin

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees
PE20 Patent expired after termination of 20 years